SENS-401 (R-Azasetron Besylate)

DRUG2 trials

Sponsors

Sensorion

Conditions

Hearing LossHearing Loss Ototoxic

Phase 2

Evaluation of the Presence of SENS-401 in the Perilymph

CompletedNCT05258773

SensorionHearing Loss

Start: 2022-08-10End: 2024-05-31Updated: 2025-04-23

SENS-401 to Prevent the Ototoxicity Induced by Cisplatin in Adult Subjects With a Neoplastic Disease

CompletedNCT05628233

SensorionHearing Loss Ototoxic

Start: 2022-12-30End: 2025-06-11Updated: 2026-07-02